MESENCHYMAL CHONDROSARCOMA
Clinical trials for MESENCHYMAL CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MESENCHYMAL CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for MESENCHYMAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested for rare, Hard-to-Treat bone cancer
Disease control OngoingThis study tested an oral drug called vismodegib in patients with advanced chondrosarcoma, a rare type of bone cancer that has spread and is difficult to treat. The main goal was to see if the drug could stop the cancer from growing for at least six months. Researchers also track…
Matched conditions: MESENCHYMAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for tough sarcomas: adding a targeted drug to standard treatment
Disease control OngoingThis study is for patients with newly diagnosed, high-risk soft tissue sarcomas that can be removed by surgery. It tests whether adding a drug called pazopanib to standard pre-surgery treatments (radiation with or without chemotherapy) helps shrink tumors more effectively and imp…
Matched conditions: MESENCHYMAL CHONDROSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC